Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials

@article{Yu2017CompoundGP,
  title={Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials},
  author={Jason Jingjie Yu and C. Zhang and M. Coyle and Y. Du and A. Zhang and Xin-feng Guo and C. Xue and Chuan-jian Lu},
  journal={Current Medical Research and Opinion},
  year={2017},
  volume={33},
  pages={279 - 287}
}
  • Jason Jingjie Yu, C. Zhang, +5 authors Chuan-jian Lu
  • Published 2017
  • Medicine
  • Current Medical Research and Opinion
  • Abstract Background: Psoriasis vulgaris is a chronic skin condition affecting patients’ quality of life. Long-term use of conventional therapy increases risk of unwanted side effects. Compound glycyrrhizin in conjunction with conventional therapy has been used in clinical practice, but the evidence for such practice has not been evaluated systematically. Objective: This review aims to evaluate the efficacy and safety of compound glycyrrhizin in combination with conventional therapy for… CONTINUE READING
    16 Citations

    Topics from this paper

    PSORI-CM02 ameliorates psoriasis in vivo and in vitro by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway.
    • 8

    References

    SHOWING 1-10 OF 52 REFERENCES
    Add-On Effect of Chinese Herbal Medicine Bath to Phototherapy for Psoriasis Vulgaris: A Systematic Review
    • 25
    • PDF
    Clinical observation and pharmacological analysis of glycyrrhizin in treating psoriasis vulgaris
    • 1
    S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update
    • A. Nast, W. Boehncke, +19 authors B. Rzany
    • Medicine
    • Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
    • 2012
    • 228
    The treatment of atopic dermatitis with licorice gel
    • 131
    • PDF
    Glycyrrhizin Ameliorates Imiquimod-Induced Psoriasis-like Skin Lesions in BALB/c Mice and Inhibits TNF-a-Induced ICAM-1 Expression via NF-κB/MAPK in HaCaT Cells
    • 43
    Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine models.
    • 83
    Definition of treatment goals for moderate to severe psoriasis: a European consensus
    • 547
    • PDF